{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:08:55Z","timestamp":1789538935094,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171341"],"award-info":[{"award-number":["82171341"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00415-025-13137-6","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T16:30:14Z","timestamp":1747413014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fluctuations in serum aquaporin-4 antibody titers: the clinical significance in neuromyelitis optica spectrum disorder"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9281-1571","authenticated-orcid":false,"given":"Zhouzhou","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8056-373X","authenticated-orcid":false,"given":"Wenjuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7784-7340","authenticated-orcid":false,"given":"Yuxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5308-6325","authenticated-orcid":false,"given":"Jingzi","family":"ZhangBao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-3930","authenticated-orcid":false,"given":"Chao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"2","key":"13137_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"issue":"7","key":"13137_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMra1904655","volume":"387","author":"DM Wingerchuk","year":"2022","unstructured":"Wingerchuk DM, Lucchinetti CF (2022) Neuromyelitis optica spectrum disorder. N Engl J Med 387(7):631\u2013639. https:\/\/doi.org\/10.1056\/NEJMra1904655","journal-title":"N Engl J Med"},{"issue":"9451","key":"13137_CR3","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106\u20132112. https:\/\/doi.org\/10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet"},{"issue":"4","key":"13137_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202(4):473\u2013477. https:\/\/doi.org\/10.1084\/jem.20050304","journal-title":"J Exp Med"},{"key":"13137_CR5","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, et al (2025). A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica - PubMed. Accessed January 26, 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/12076996\/"},{"issue":"4","key":"13137_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncpneuro0764","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D et al (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4(4):202\u2013214. https:\/\/doi.org\/10.1038\/ncpneuro0764","journal-title":"Nat Clin Pract Neurol"},{"issue":"Pt 5","key":"13137_CR7","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu T, Fujihara K, Kakita A et al (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130(Pt 5):1224\u20131234. https:\/\/doi.org\/10.1093\/brain\/awm047","journal-title":"Brain"},{"issue":"Pt 5","key":"13137_CR8","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA et al (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130(Pt 5):1194\u20131205. https:\/\/doi.org\/10.1093\/brain\/awl371","journal-title":"Brain"},{"issue":"24","key":"13137_CR9","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"SR Hinson","year":"2007","unstructured":"Hinson SR, Pittock SJ, Lucchinetti CF et al (2007) Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 69(24):2221\u20132231. https:\/\/doi.org\/10.1212\/01.WNL.0000289761.64862.ce","journal-title":"Neurology"},{"issue":"7","key":"13137_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/archneur.65.7.913","volume":"65","author":"P Waters","year":"2008","unstructured":"Waters P, Jarius S, Littleton E et al (2008) Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 65(7):913\u2013919. https:\/\/doi.org\/10.1001\/archneur.65.7.913","journal-title":"Arch Neurol"},{"issue":"Pt 11","key":"13137_CR11","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1093\/brain\/awn240","volume":"131","author":"S Jarius","year":"2008","unstructured":"Jarius S, Aboul-Enein F, Waters P et al (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131(Pt 11):3072\u20133080. https:\/\/doi.org\/10.1093\/brain\/awn240","journal-title":"Brain"},{"key":"13137_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflamm 9:14. https:\/\/doi.org\/10.1186\/1742-2094-9-14","journal-title":"J Neuroinflamm"},{"key":"13137_CR13","doi-asserted-by":"publisher","first-page":"746959","DOI":"10.3389\/fneur.2021.746959","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Tan G, Li B et al (2021) Serum aquaporin 4-immunoglobulin G titer and neuromyelitis optica spectrum disorder activity and severity: a systematic review and meta-analysis. Front Neurol 12:746959. https:\/\/doi.org\/10.3389\/fneur.2021.746959","journal-title":"Front Neurol"},{"issue":"Pt 5","key":"13137_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/brain\/awm062","volume":"130","author":"T Takahashi","year":"2007","unstructured":"Takahashi T, Fujihara K, Nakashima I et al (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titer. Brain 130(Pt 5):1235\u20131243. https:\/\/doi.org\/10.1093\/brain\/awm062","journal-title":"Brain"},{"issue":"6","key":"13137_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/ana.26623","volume":"93","author":"HX Yin","year":"2023","unstructured":"Yin HX, Wang YJ, Liu MG et al (2023) Aquaporin-4 antibody dynamics and relapse risk in seropositive neuromyelitis optica spectrum disorder treated with immunosuppressants. Ann Neurol 93(6):1069\u20131081. https:\/\/doi.org\/10.1002\/ana.26623","journal-title":"Ann Neurol"},{"key":"13137_CR16","doi-asserted-by":"publisher","first-page":"635419","DOI":"10.3389\/fneur.2021.635419","volume":"12","author":"O Schmetzer","year":"2021","unstructured":"Schmetzer O, Lakin E, Roediger B et al (2021) Anti-aquaporin 4 IgG is not associated with any clinical disease characteristics in neuromyelitis optica spectrum disorder. Front Neurol 12:635419. https:\/\/doi.org\/10.3389\/fneur.2021.635419","journal-title":"Front Neurol"},{"key":"13137_CR17","doi-asserted-by":"publisher","first-page":"116671","DOI":"10.1016\/j.jns.2020.116671","volume":"410","author":"T Akaishi","year":"2020","unstructured":"Akaishi T, Takahashi T, Nakashima I et al (2020) Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD). J Neurol Sci 410:116671. https:\/\/doi.org\/10.1016\/j.jns.2020.116671","journal-title":"J Neurol Sci"},{"key":"13137_CR18","unstructured":"Hyun JW, Woodhall MR, Huda S, et al (2025). Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD - PubMed. Accessed January 26, 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/35413004\/"},{"issue":"4","key":"13137_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ana.26722","volume":"94","author":"M Majed","year":"2023","unstructured":"Majed M, Valencia Sanchez C, Bennett JL et al (2023) Alterations in aquaporin-4-IgG serostatus in 986 patients: a laboratory-based longitudinal analysis. Ann Neurol 94(4):727\u2013735. https:\/\/doi.org\/10.1002\/ana.26722","journal-title":"Ann Neurol"},{"issue":"10","key":"13137_CR20","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/acn3.52171","volume":"11","author":"JL Bennett","year":"2024","unstructured":"Bennett JL, Pittock SJ, Paul F et al (2024) B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity. Ann Clin Transl Neurol 11(10):2792\u20132798. https:\/\/doi.org\/10.1002\/acn3.52171","journal-title":"Ann Clin Transl Neurol"},{"issue":"18","key":"13137_CR21","doi-asserted-by":"publisher","first-page":"e1732","DOI":"10.1212\/WNL.0000000000008394","volume":"93","author":"RK Burt","year":"2019","unstructured":"Burt RK, Balabanov R, Han X et al (2019) Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica. Neurology 93(18):e1732\u2013e1741. https:\/\/doi.org\/10.1212\/WNL.0000000000008394","journal-title":"Neurology"},{"issue":"3","key":"13137_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/ana.24079","volume":"75","author":"R Greco","year":"2014","unstructured":"Greco R, Bondanza A, Vago L et al (2014) Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. Ann Neurol 75(3):447\u2013453. https:\/\/doi.org\/10.1002\/ana.24079","journal-title":"Ann Neurol"},{"issue":"8","key":"13137_CR23","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1111\/ene.15355","volume":"29","author":"W Huang","year":"2022","unstructured":"Huang W, Wang L, Xia J et al (2022) Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder. Eur J Neurol 29(8):2343\u20132354. https:\/\/doi.org\/10.1111\/ene.15355","journal-title":"Eur J Neurol"},{"key":"13137_CR24","doi-asserted-by":"publisher","first-page":"873576","DOI":"10.3389\/fimmu.2022.873576","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Du L, Li Q et al (2022) Neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibody: outcome prediction models. Front Immunol 13:873576. https:\/\/doi.org\/10.3389\/fimmu.2022.873576","journal-title":"Front Immunol"},{"issue":"4","key":"13137_CR25","doi-asserted-by":"publisher","first-page":"e20241253","DOI":"10.1084\/jem.20241253","volume":"222","author":"H Peckham","year":"2025","unstructured":"Peckham H, Radziszewska A, Sikora J et al (2025) Estrogen influences class-switched memory B cell frequency only in humans with two X chromosomes. J Exp Med 222(4):e20241253. https:\/\/doi.org\/10.1084\/jem.20241253","journal-title":"J Exp Med"},{"issue":"1","key":"13137_CR26","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1186\/s12967-024-05990-2","volume":"22","author":"Z Feng","year":"2024","unstructured":"Feng Z, Liao M, Zhang L (2024) Sex differences in disease: sex chromosome and immunity. J Transl Med 22(1):1150. https:\/\/doi.org\/10.1186\/s12967-024-05990-2","journal-title":"J Transl Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13137-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13137-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13137-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T13:25:21Z","timestamp":1749907521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13137-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["13137"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13137-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study involves human participants and was approved by the Medical Ethics Committee of Huashan Hospital (HIRB-KY2024-1414). Participants gave informed consent to participate in the study before taking part.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"403"}}